Antibodies targeting marburgvirus glycoproteins and uses thereof

Abstract

The present disclosure relates generally to antibodies, such as antibodies and fragments thereof, that bind to the marburgvirus glycoprotein. Such antibodies have many applications including their use as antiviral drugs for treatment and prevention of diseases resulting from marburgvirus infection.

Dependencies are inferred from the claim text.